cabozantinib
exelixis
['atlantis', 'cabozantinib', 'urothelial']
#asco22 news: atlantis platform trial findings presented by robert jones ( ) &amp; discussed by ( ) rule out the use of cabozantinib as maintenance therapy in patients with metastatic urothelial cancer 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.